These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 24924344)

  • 1. Application of next generation sequencing to CEPH cell lines to discover variants associated with FDA approved chemotherapeutics.
    Hariani GD; Lam ET; Havener T; Kwok PY; McLeod HL; Wagner MJ; Motsinger-Reif AA
    BMC Res Notes; 2014 Jun; 7():360. PubMed ID: 24924344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel anti-glioblastoma agents and therapeutic combinations identified from a collection of FDA approved drugs.
    Jiang P; Mukthavaram R; Chao Y; Bharati IS; Fogal V; Pastorino S; Cong X; Nomura N; Gallagher M; Abbasi T; Vali S; Pingle SC; Makale M; Kesari S
    J Transl Med; 2014 Jan; 12():13. PubMed ID: 24433351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of thymidylate synthase variants with 5-fluorouracil cytotoxicity.
    Peters EJ; Kraja AT; Lin SJ; Yen-Revollo JL; Marsh S; Province MA; McLeod HL
    Pharmacogenet Genomics; 2009 May; 19(5):399-401. PubMed ID: 19339911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of CEPH and non-CEPH lymphoblast cell lines in pharmacogenetic studies.
    Shukla SJ; Dolan ME
    Pharmacogenomics; 2005 Apr; 6(3):303-10. PubMed ID: 16013961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Huvariome: a web server resource of whole genome next-generation sequencing allelic frequencies to aid in pathological candidate gene selection.
    Stubbs A; McClellan EA; Horsman S; Hiltemann SD; Palli I; Nouwens S; Koning AH; Hoogland F; Reumers J; Heijsman D; Swagemakers S; Kremer A; Meijerink J; Lambrechts D; van der Spek PJ
    J Clin Bioinforma; 2012 Nov; 2(1):19. PubMed ID: 23164068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concurrent exome-targeted next-generation sequencing and single nucleotide polymorphism array to identify the causative genetic aberrations of isolated Mayer-Rokitansky-Küster-Hauser syndrome.
    Chen MJ; Wei SY; Yang WS; Wu TT; Li HY; Ho HN; Yang YS; Chen PL
    Hum Reprod; 2015 Jul; 30(7):1732-42. PubMed ID: 25924657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Genetic Variations in NRF2, NQO1, HMOX1, and MT with Severity of Coronary Artery Disease and Related Risk Factors.
    Sarutipaiboon I; Settasatian N; Komanasin N; Kukongwiriyapan U; Sawanyawisuth K; Intharaphet P; Senthong V; Settasatian C
    Cardiovasc Toxicol; 2020 Apr; 20(2):176-189. PubMed ID: 31332605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole genome and normalized mRNA sequencing reveal genetic status of TK6, WTK1, and NH32 human B-lymphoblastoid cell lines.
    Revollo J; Petibone DM; McKinzie P; Knox B; Morris SM; Ning B; Dobrovolsky VN
    Mutat Res Genet Toxicol Environ Mutagen; 2016 Jan; 795():60-9. PubMed ID: 26774668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment recommendations to cancer patients in the context of FDA guidance for next generation sequencing.
    Dy GK; Nesline MK; Papanicolau-Sengos A; DePietro P; LeVea CM; Early A; Chen H; Grand'Maison A; Boland P; Ernstoff MS; Edge S; Akers S; Opyrchal M; Chatta G; Odunsi K; Pabla S; Conroy JM; Glenn ST; DeFedericis HT; Burgher B; Andreas J; Giamo V; Qin M; Wang Y; Kanehira K; Lenzo FL; Frederick P; Lele S; Galluzzi L; Kuvshinoff B; Morrison C
    BMC Med Inform Decis Mak; 2019 Jan; 19(1):14. PubMed ID: 30658646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenomic characterization of US FDA-approved cytotoxic drugs.
    Peters EJ; Motsinger-Reif A; Havener TM; Everitt L; Hardison NE; Watson VG; Wagner M; Richards KL; Province MA; McLeod HL
    Pharmacogenomics; 2011 Oct; 12(10):1407-15. PubMed ID: 22008047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic association with overall survival of taxane-treated lung cancer patients - a genome-wide association study in human lymphoblastoid cell lines followed by a clinical association study.
    Niu N; Schaid DJ; Abo RP; Kalari K; Fridley BL; Feng Q; Jenkins G; Batzler A; Brisbin AG; Cunningham JM; Li L; Sun Z; Yang P; Wang L
    BMC Cancer; 2012 Sep; 12():422. PubMed ID: 23006423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variation predicting cisplatin cytotoxicity associated with overall survival in lung cancer patients receiving platinum-based chemotherapy.
    Tan XL; Moyer AM; Fridley BL; Schaid DJ; Niu N; Batzler AJ; Jenkins GD; Abo RP; Li L; Cunningham JM; Sun Z; Yang P; Wang L
    Clin Cancer Res; 2011 Sep; 17(17):5801-11. PubMed ID: 21775533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-throughput screening and genome-wide analyses of 44 anticancer drugs in the 1000 Genomes cell lines reveals an association of the NQO1 gene with the response of multiple anticancer drugs.
    Akhtari FS; Green AJ; Small GW; Havener TM; House JS; Roell KR; Reif DM; McLeod HL; Wiltshire T; Motsinger-Reif AA
    PLoS Genet; 2021 Aug; 17(8):e1009732. PubMed ID: 34437536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A unified approach for allele frequency estimation, SNP detection and association studies based on pooled sequencing data using EM algorithms.
    Chen Q; Sun F
    BMC Genomics; 2013; 14 Suppl 1(Suppl 1):S1. PubMed ID: 23369070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Copy number variation and cytidine analogue cytotoxicity: a genome-wide association approach.
    Kalari KR; Hebbring SJ; Chai HS; Li L; Kocher JP; Wang L; Weinshilboum RM
    BMC Genomics; 2010 Jun; 11():357. PubMed ID: 20525348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide local ancestry approach identifies genes and variants associated with chemotherapeutic susceptibility in African Americans.
    Wheeler HE; Gorsic LK; Welsh M; Stark AL; Gamazon ER; Cox NJ; Dolan ME
    PLoS One; 2011; 6(7):e21920. PubMed ID: 21755009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FDA approval, clinical trial evidence, efficacy, epidemiology, and price for non-orphan and ultra-rare, rare, and common orphan cancer drug indications: cross sectional analysis.
    Michaeli T; Jürges H; Michaeli DT
    BMJ; 2023 May; 381():e073242. PubMed ID: 37160306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Large-Scale Drug Screening in Patient-Derived IDH
    Dao Trong P; Jungwirth G; Yu T; Pusch S; Unterberg A; Herold-Mende C; Warta R
    Cells; 2020 Jun; 9(6):. PubMed ID: 32503220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of VKORC1, CYP4F2 and NQO1 gene variants on warfarin dose requirement in Han Chinese patients with catheter ablation for atrial fibrillation.
    Li J; Yang W; Xie Z; Yu K; Chen Y; Cui K
    BMC Cardiovasc Disord; 2018 May; 18(1):96. PubMed ID: 29776386
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.